ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2883

Testing for Anti-Microbial Antibodies with Cross-Reactivity to Human Tissue in Autoimmune Diseases

Peilin Zhang, Lawrence Minardi, J. Todd Kuenstner and Stephen Zekan, PZM Diagnostics, LLC, Charleston, WV

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: anti-mitochondria antibody, Autoantibodies and autoimmune diseases, Crohn's Disease, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T110 ACR Abstract: Sjögren's Syndrome–Basic & Clinical Science (2880–2885)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Autoantibodies are defining features of autoimmune diseases. How and why the autoantibodies are produced and how these autoantibodies relate to pathogenesis is poorly understood. Current study is to examine the role of anti-microbial antibodies in patients with Sjogren’s syndrome and Crohn’s disease.

Methods:

We have discovered a panel of serology biomarkers against microbial antigens through Western blot analysis, mass spectrometry, immunohistochemistry and ELISA assays.

Results:

We have discovered a novel panel of anti-microbial antibodies from the blood of patients with Sjogren’s syndrome and Crohn’s disease, and these antimicrobial antibodies are significantly elevated in the patients in comparison to the healthy controls. The anti-microbial antibodies are directed to RPOB (S135) from S. aureus, EF-G (S75) from S. aureus/pseudintermedius, Hsp65 (M60) from Mycobacterium, ATP5a (S55) from S. aureus and EF-Tu (E41) from E. coli. These bacteria are commensal commonly present on the surface of human body, in the gut, and environment. Specific monoclonal and polyclonal antibodies against these microbial proteins can cross-react to the normal human tissues by immunohistochemistry. We have tested 23 patients with Sjogren’s and 45 patients with Crohn’s disease for the blood levels of these anti-microbial antibodies below in comparison to 288 normal controls. We also found these anti-microbial antibodies are elevated in patients with systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis and Lyme disease.

Conclusion:

The defining features of autoantibodies in autoimmune diseases may in fact be anti-microbial antibodies with cross-reactivity to human tissues. The presence of anti-microbial antibodies with cross-reactivity to human tissue may provide a basis of pathogenesis in autoimmune disease through molecular mimicry and offer new direction of research in disease mechanisms and therapeutics for a spectrum of autoimmune diseases.


Disclosure: P. Zhang, Owner of the company, 4; L. Minardi, PZM Diagnostics, LLC, 4; J. T. Kuenstner, PZM Diagnostics, LLC, 4; S. Zekan, PZM Diagnostics, LLC, 4.

To cite this abstract in AMA style:

Zhang P, Minardi L, Kuenstner JT, Zekan S. Testing for Anti-Microbial Antibodies with Cross-Reactivity to Human Tissue in Autoimmune Diseases [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/testing-for-anti-microbial-antibodies-with-cross-reactivity-to-human-tissue-in-autoimmune-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/testing-for-anti-microbial-antibodies-with-cross-reactivity-to-human-tissue-in-autoimmune-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology